Univercells Technologies, a global provider of next-gen bioprocess technologies, has been launched as a subsidiary of Univercells, under which it will focus on the commercialization of the product portfolio and explore new technology developments to expand its position in the cell and gene therapy market.    According to Mathias Garny, General Manager of Univercells Technologies, “With the scale – X bioreactor portfolio and the NevoLine biomanufacturing platform, designed and commercial...